Company news

Share this article:
Pfizer announced that it has completed the acquisition of all remaining outstanding shares of common stock of Encysive Pharmaceuticals through a merger of Pfizer's wholly owned subsidiary, Explorer Acquisition Corp. 

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions